Clinical Trial Update: The Effect of Oral β- Glucan Supplement on Appetite and Insulin Resistance in Non Alcoholic Fatty Liver Disease [NA]

View source ↗

Summary

An update on a clinical trial evaluating the effect of an oral beta-glucan supplement on appetite and insulin resistance in nonalcoholic fatty liver disease. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease

Drugs mentioned

• Beta-glucan supplement (beta-glucan)

Snippet

Sponsor: Urmia University of Medical Sciences | Conditions: Non Alcoholic Fatty Liver Disease | NA | Status: UNKNOWN